tm
Seeing Is Believing
tm
Seeing Is Believing
MLTX is currently covered by 9 analysts with an average price target of $88.53. This is a potential upside of $33.46 (60.76%) from yesterday's end of day stock price of $55.07.
MoonLake Immunotherapeutics's activity chart (see below) currently has 29 price targets and 77 ratings on display. The stock rating distribution of MLTX is 98.25% BUY and 1.75% HOLD.
Analysts average stock forecasts to be materialized ratio is 20.09% with an average time for these price targets to be met of 45.89 days.
Highest price target for MLTX is $100, Lowest price target is $66, average price target is $78.25.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 13-May-2025. First documented stock forecast 21-Jul-2022.
Currently out of the existing stock ratings of MLTX, 56 are a BUY (98.25%), 1 are a HOLD (1.75%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$66
$10.93 (19.85%)
$66
2 months 14 days ago
(13-May-2025)
0/13 (0%)
$27.46 (71.25%)
Buy
$100
$44.93 (81.59%)
$100
5 months ago
(27-Feb-2025)
8/27 (29.63%)
$57.63 (136.02%)
86
Buy
$73
$17.93 (32.56%)
$82
5 months ago
(27-Feb-2025)
0/3 (0%)
$30.63 (72.29%)
Buy
10 months 4 days ago
(23-Sep-2024)
3/7 (42.86%)
$37.82 (94.13%)
35
Buy
$104
$48.93 (88.85%)
$92
1 years 1 months 2 days ago
(25-Jun-2024)
1/12 (8.33%)
$64.3 (161.96%)
96
What is MLTX (MoonLake Immunotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MLTX (MoonLake Immunotherapeutics) with a proven track record?
Which analyst has the current lower performing score on MLTX (MoonLake Immunotherapeutics) with a proven track record?
Which analyst has the most public recommendations on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most bullish on MLTX (MoonLake Immunotherapeutics)?
Which analyst is the currently most reserved on MLTX (MoonLake Immunotherapeutics)?
